Medivolve Announces Appointment of David Preiner as New Chief Executive Officer

Medivolve

Toronto, Ontario April 30, 2021 — Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) a healthcare investment management company that seeks out disruptive technologies, ground-breaking innovations and exclusive partnerships to help combat COVID-19, today announced that David Preiner has been appointed Chief Executive Officer (CEO), effective immediately. Preiner will succeed Doug Sommerville, who will assist as a transitionary…

Medivolve Announces an Investor Webinar Today at 1 pm ET

Medivolve

Toronto, Ontario April 15th, 2021 — Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) is pleased to announce it is hosting a Corporate Update webinar, on Thursday, April 15th  at 1 pm ET that will provide investors with an update on the Company’s recent business developments.  Registration Link:  https://us02web.zoom.us/webinar/register/WN_pRyhGijjSgCGKKsE90lMPQ  Specifically, the webinar will feature Medivolve CEO Doug Sommerville as…

Collection Sites, LLC Named AditxtScore™ Channel Partner to Offer AditxtScore™ for COVID-19 Immunity Status Monitoring to Mobile Testing Centres Across the United States

Medivolve

Toronto, Ontario April 1, 2021 — Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) today announced that its wholly owned subsidiary, Collection Sites, LLC will offer  AditxtScore™ for COVID-19 through its mobile testing centres.  Aditx Therapeutics (Nasdaq: ADTX), is a biotech innovation company focused on improving the health of the immune system. Collection Sites, LLC provides testing…